Nanjing King-Friend Pharmaceutical Co., Ltd. is a pharmaceutical group integrating drug research and development, production and distribution.We're dedicated to providing high-end sterile injectables.
Our products
We have world-leading isolator production lines, advanced aseptic injection manufacturing technology, and a global quality system certified by multiple regions including the United States, Europe,China,Japan, and Brazil.
-
Generics
-
Brands
Addressing unmet needs in the bio-pharma industry,Focusing on developing impactful products
-
Biologics
Unwavering commitment to making affordable treatments a real, accessible option for patients.
-
API
Years of consistent experience makes us a leading global supplier of heparin API.
We spare no effort in pursuing better treatments—from the development of new drugs to the improvement of package forms.
About King-Friend
Headquartered in Nanjing,China,NKF brings to market innovative and impactful biopharmaceutical products with its global strategy.
-
80+ANDA approvals -
9+Biosimilars -
3+Innovatives
At NKF, we strive to build a world-class team,innovating life-enhancing products for both humanity and our planet, and fulfilling our commitment to environmental protection.
-
-
-
Every year, we review the work we’ve done to advance CSR across King-Friend. -
Latest News
-
Company NewsNKF's Propofol Injectable Emulsion has been approved by the US FDA and is about to enter the US market!
Dec 05,2025 -
Company NewsNKF's subsidiary Kindos's Dalbavancin for Injection gets FDA approval for marketing
Dec 03,2025 -
Company NewsNKF sincerely invites global customers to gather at CPHI Europe to explore new opportunities for cooperation together!
Oct 21,2025 -
Company NewsNKF attended the 25th anniversary celebration of GMS in Pakistan to deepen strategic cooperation
Oct 17,2025 -
Company NewsNKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
Aug 04,2025 -
Company NewsNKF makes its debut at CPHI Southeast Asia
Jul 21,2025 -
Company NewsKing-Friend will meet you in CPHI Malaysia!
Jul 14,2025 -
Company NewsNKF's subsidiary Kindos's Hydralazine Hydrochloride Injection gets FDA
Jun 09,2025